ALFREDO
RODRIGUEZ-ANTIGUEDAD ZARRANZ
PROFESORADO ASOCIADO
Universidad Complutense de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadoras/es de Universidad Complutense de Madrid (5)
2024
-
Beyond lines of treatment: embracing early high-efficacy disease-modifying treatments for multiple sclerosis management
Therapeutic Advances in Neurological Disorders, Vol. 17
-
Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: Discover study
Multiple Sclerosis and Related Disorders, Vol. 90
-
Defining a standard set of health outcomes for patients with relapsing-remitting multiple sclerosis
Multiple Sclerosis and Related Disorders, Vol. 84
2022
-
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
Neurologia, Vol. 37, Núm. 8, pp. 615-630
-
Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology
Multiple Sclerosis and Related Disorders, Vol. 63